BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21725800)

  • 1. Expression analysis of stem cell-related genes reveal OCT4 as a predictor of poor clinical outcome in medulloblastoma.
    Rodini CO; Suzuki DE; Saba-Silva N; Cappellano A; de Souza JE; Cavalheiro S; Toledo SR; Okamoto OK
    J Neurooncol; 2012 Jan; 106(1):71-9. PubMed ID: 21725800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-367 promotes proliferation and stem-like traits in medulloblastoma cells.
    Kaid C; Silva PB; Cortez BA; Rodini CO; Semedo-Kuriki P; Okamoto OK
    Cancer Sci; 2015 Sep; 106(9):1188-95. PubMed ID: 26250335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastoma.
    Raso A; Mascelli S; Biassoni R; Nozza P; Kool M; Pistorio A; Ugolotti E; Milanaccio C; Pignatelli S; Ferraro M; Pavanello M; Ravegnani M; Cama A; Garrè ML; Capra V
    Neuro Oncol; 2011 May; 13(5):500-8. PubMed ID: 21486962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.
    Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embryonic Stem Cell-Related Protein L1TD1 Is Required for Cell Viability, Neurosphere Formation, and Chemoresistance in Medulloblastoma.
    Santos MC; Silva PB; Rodini CO; Furukawa G; Marco Antonio DS; Zanotto-Filho A; Moreira JC; Okamoto OK
    Stem Cells Dev; 2015 Nov; 24(22):2700-8. PubMed ID: 26159230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation-related DNA damage and expression of CD133 and Oct3/4 in cholangiocarcinoma patients with poor prognosis.
    Thanan R; Pairojkul C; Pinlaor S; Khuntikeo N; Wongkham C; Sripa B; Ma N; Vaeteewoottacharn K; Furukawa A; Kobayashi H; Hiraku Y; Oikawa S; Kawanishi S; Yongvanit P; Murata M
    Free Radic Biol Med; 2013 Dec; 65():1464-1472. PubMed ID: 23917144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2.
    Iida H; Suzuki M; Goitsuka R; Ueno H
    Int J Oncol; 2012 Jan; 40(1):71-9. PubMed ID: 21947321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy.
    Saigusa S; Tanaka K; Toiyama Y; Yokoe T; Okugawa Y; Ioue Y; Miki C; Kusunoki M
    Ann Surg Oncol; 2009 Dec; 16(12):3488-98. PubMed ID: 19657699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells.
    Jia Q; Zhang X; Deng T; Gao J
    Cell Reprogram; 2013 Apr; 15(2):143-50. PubMed ID: 23438193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High OCT4A levels drive tumorigenicity and metastatic potential of medulloblastoma cells.
    da Silva PBG; Teixeira Dos Santos MC; Rodini CO; Kaid C; Pereira MCL; Furukawa G; da Cruz DSG; Goldfeder MB; Rocha CRR; Rosenberg C; Okamoto OK
    Oncotarget; 2017 Mar; 8(12):19192-19204. PubMed ID: 28186969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
    Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
    Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of suitable endogenous control genes for microRNA expression profiling of childhood medulloblastoma and human neural stem cells.
    Genovesi LA; Anderson D; Carter KW; Giles KM; Dallas PB
    BMC Res Notes; 2012 Sep; 5():507. PubMed ID: 22980291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevating SOX2 levels deleteriously affects the growth of medulloblastoma and glioblastoma cells.
    Cox JL; Wilder PJ; Desler M; Rizzino A
    PLoS One; 2012; 7(8):e44087. PubMed ID: 22937156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of Musashi-1 in endometrioid adenocarcinoma.
    Ma L; Xu YL; Ding WJ; Shao HF; Teng YC
    Int J Clin Exp Pathol; 2015; 8(5):4564-72. PubMed ID: 26191146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humanized Stem Cell Models of Pediatric Medulloblastoma Reveal an Oct4/mTOR Axis that Promotes Malignancy.
    Čančer M; Hutter S; Holmberg KO; Rosén G; Sundström A; Tailor J; Bergström T; Garancher A; Essand M; Wechsler-Reya RJ; Falk A; Weishaupt H; Swartling FJ
    Cell Stem Cell; 2019 Dec; 25(6):855-870.e11. PubMed ID: 31786016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma.
    Remke M; Hielscher T; Korshunov A; Northcott PA; Bender S; Kool M; Westermann F; Benner A; Cin H; Ryzhova M; Sturm D; Witt H; Haag D; Toedt G; Wittmann A; Schöttler A; von Bueren AO; von Deimling A; Rutkowski S; Scheurlen W; Kulozik AE; Taylor MD; Lichter P; Pfister SM
    J Clin Oncol; 2011 Oct; 29(29):3852-61. PubMed ID: 21911727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell marker CD133 affects clinical outcome in glioma patients.
    Zeppernick F; Ahmadi R; Campos B; Dictus C; Helmke BM; Becker N; Lichter P; Unterberg A; Radlwimmer B; Herold-Mende CC
    Clin Cancer Res; 2008 Jan; 14(1):123-9. PubMed ID: 18172261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA142-3p promotes tumor-initiating and radioresistant properties in malignant pediatric brain tumors.
    Lee YY; Yang YP; Huang MC; Wang ML; Yen SH; Huang PI; Chen YW; Chiou SH; Lan YT; Ma HI; Shih YH; Chen MT
    Cell Transplant; 2014; 23(4-5):669-90. PubMed ID: 24816458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel gene expression model for outcome prediction in paediatric medulloblastoma.
    Zakrzewska M; Grešner SM; Zakrzewski K; Zalewska-Szewczyk B; Liberski PP
    J Mol Neurosci; 2013 Oct; 51(2):371-9. PubMed ID: 23649504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD133 in acute leukemia.
    Tolba FM; Foda ME; Kamal HM; Elshabrawy DA
    Med Oncol; 2013 Jun; 30(2):527. PubMed ID: 23532815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.